StockWatch
·
Biotechnology: Biological Products (No Diagnostic Substances)
CybersecurityJul 31, 2026, 04:13 PM

Amgen Reports Material Cybersecurity Incident, Data Exfiltrated

AI Summary

Amgen Inc. identified unauthorized activity in its third-party cloud environments in July 2026, leading to the exfiltration of proprietary data and patient protected health information. The company activated its cybersecurity response plan and engaged forensic experts. While the investigation is ongoing, Amgen has not identified any impact on its products, manufacturing operations, or financial reporting systems. The incident was deemed material on July 29, 2026, though the company currently believes it is not reasonably likely to have a material impact on its financial condition or results of operations.

Key Highlights

  • Amgen identified unauthorized activity in cloud environments in July 2026.
  • Proprietary data and patient protected health information were exfiltrated.
  • No impact identified on products, manufacturing, or financial reporting systems.
  • Incident determined to be material on July 29, 2026.
  • Investigation is ongoing to assess the full extent of the breach.
  • Company believes no material impact on financial condition or results of operations.